Chappaqua, NY, United States of America

Lori C Morton

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Tarrytown, NY (US) (2020)
  • Chappaqua, NY (US) (2017 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovations of Lori C. Morton: Pioneering Advances in Biomedical Science

Introduction: Lori C. Morton, based in Chappaqua, NY, is a prolific inventor with 15 patents to her name. Her groundbreaking work primarily focuses on innovative methods that intertwine genetics and biomedical applications. Lori has significantly contributed to the understanding and treatment of blood clotting disorders, utilizing her expertise to develop novel solutions.

Latest Patents: Among her most recent patents, Lori has developed a method that employs a genetically modified mouse designed to express human albumin. This innovation involves non-human animal genomes, cells, and species that incorporate a humanized albumin locus. These advancements allow for the assessment of in vivo efficacy of human-albumin-targeting reagents, including designed nuclease agents targeting human albumin. Additionally, she has created antibodies binding to the A2 domain of Factor XI, demonstrating potential therapeutic applications for blood clotting diseases while preserving hemostasis. These antagonist antibodies may serve as vital treatments for conditions characterized by excessive clot formation, such as atrial fibrillation.

Career Highlights: Lori's career is marked by her tenure at Regeneron Pharmaceuticals, Inc., where her research excels in the intersection of genetics and therapeutic development. Her contributions have propelled advancements in both scientific understanding and practical applications in the biomedical field.

Collaborations: Throughout her career, Lori has worked alongside notable colleagues, including Dan Chalothorn and Jesper Gromada, forming a collaborative network that fosters innovative ideas and solutions in patent development.

Conclusion: Lori C. Morton exemplifies the spirit of innovation in the life sciences sector. Her patents not only reflect her ingenuity but also her commitment to improving medical outcomes through targeted therapeutic strategies. As she continues to pioneer in her field, her work remains a testament to the impact of innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…